Table 5.
Incidence of erythema following exposure to test articles
| Formulation | Incidence of erythema (% dosing events) |
|---|---|
| DCF100C2 (2.5%) | 5% |
| DCF100C2 (1%) | 10% |
| DCF100C1 (2.5%) | 25% |
| DCF100C1 (1%) | 20% |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.